Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatics Inks Deal for Biopendium, Chematica Technologies with Schering

NEW YORK, Oct. 17 (GenomeWeb News) - Inpharmatica said today that it has formed a collaboration with German drugmaker Schering to study protein structures in order to prioritize proteins as drug targets. 

 

Under the deal, Inpharmatica will make available to Schering its Biopendium and Chematica technologies, which include databases with information on protein sequence, structure, and function, as well as information about the ability of particular proteins to serve as drug targets.

 

Financial terms of the deal were not disclosed.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.